Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Retraction Note: Chitosan Nanoparticles of Gamma-Oryzanol: Formulation, Optimization, and In vivo Evaluation of Anti-hyperlipidemic Activity.
Journal: AAPS PharmSciTech
Published: February 27, 2026
Chitosan Nanoparticles of Gamma-Oryzanol: Formulation, Optimization, and In vivo Evaluation of Anti-hyperlipidemic Activity.
Journal: AAPS PharmSciTech
Published: December 25, 2017
Showing 1-2 of 2
Last Updated: 09/26/2026